Acurx Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 02/11/2025 | 529,349 | $430,890 | 0.00% | 3.23% |
PROSPECT FINANCIAL SERVICES LLC | 01/22/2025 | 329,076 | $267,868 | 11.52% | 2.01% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 146,500 | $119,267 | 0.00% | 0.90% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 48,374 | $39,376 | 100.00% | 0.30% |
STATE STREET CORP | 02/14/2025 | 43,466 | $35,381 | 0.00% | 0.27% |
VIRTU FINANCIAL LLC | 02/11/2025 | 27,836 | $23,000 | 100.00% | 0.17% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 25,911 | $21,091 | -9.20% | 0.16% |
ACT ADVISORS, LLC. | 01/13/2025 | 21,284 | $17,325 | 100.00% | 0.13% |
TD WATERHOUSE CANADA INC. | 02/13/2025 | 18,656 | $14,925 | 0.00% | 0.11% |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/14/2025 | 17,750 | $14,000 | 100.00% | 0.11% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 14,674 | $11,945 | 100.00% | 0.09% |
ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 14,175 | $25,928 | -0.25% | 0.09% |
SQUAREPOINT OPS LLC | 02/14/2025 | 12,537 | $10,205 | 100.00% | 0.08% |
PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC | 01/22/2025 | 10,385 | $8,453 | 0.00% | 0.06% |
UBS GROUP AG | 02/14/2025 | 5,961 | $4,852 | 100.00% | 0.04% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 4,447 | $3,620 | 115.35% | 0.03% |
CORNERSTONE PLANNING GROUP LLC | 01/29/2025 | 3,344 | $2,809 | 0.00% | 0.02% |
GROUP ONE TRADING, L.P. | 02/14/2025 | 1,165 | $948 | 573.41% | 0.01% |
GPS WEALTH STRATEGIES GROUP, LLC | 01/24/2025 | 500 | $407 | 0.00% | 0.00% |
02/06/2025 | 270 | $220 | 100.00% | 0.00% | |
NBC SECURITIES, INC. | 01/22/2025 | 19 | $15 | -99.90% | 0.00% |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
LPL FINANCIAL LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
SIMPLEX TRADING, LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
Acurx Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 30 institutional investors and hedge funds held shares of Acurx Pharmaceuticals, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 529,349
Prospect Financial Services LLC: 329,076
GEODE CAPITAL MANAGEMENT, LLC: 146,500
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 48,374
STATE STREET CORP: 43,466
Virtu Financial LLC: 27,836
8.62% of Acurx Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.38 M shares in the last 24 months. This purchase volume represents approximately $1.51 M in transactions.